Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials
Sign Up to like & getrecommendations! Published in 2021 at "Japanese Journal of Ophthalmology"
DOI: 10.1007/s10384-021-00869-x
Abstract: Anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) has been evaluated in clinical trials. To select the best anti-VEGF drug and the best treatment regimen for nAMD, a thorough understanding of the characteristics of each… read more here.
Keywords: anti vegf; treatment; treatment neovascular; vegf treatment ... See more keywords
Treatment for neovascular age‐related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register
Sign Up to like & getrecommendations! Published in 2017 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13539
Abstract: To present Swedish Macula Register (SMR) data regarding treatment of neovascular age‐related macular degeneration (AMD) in clinical practice since 2008. read more here.
Keywords: age related; related macular; treatment neovascular; macula register ... See more keywords
Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2020-317563
Abstract: Background For treatment of neovascular age-related macular degeneration (nAMD), multiple intravitreal injections of drugs targeting vascular endothelial growth factors (VEGF) result in a high burden for patients and healthcare systems. Low-energy stereotactic radiotherapy (SRT) might… read more here.
Keywords: anti vegf; stereotactic radiotherapy; long term; treatment ... See more keywords